Patents Assigned to GENON BIOTECHNOLOGIES OY
  • Patent number: 8841078
    Abstract: The present invention relates to a dual activity domain of JAK proteins, namely JH2. It is provided that the JH2 domain is a true and important target for drug development, especially for diseases caused by aberrant JAK signalling, such as myeloproliferative disorders and leukemias.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: September 23, 2014
    Assignee: Genon Biotechnologies Oy
    Inventors: Olli Silvennoinen, Daniela Ungureanu
  • Publication number: 20120309023
    Abstract: The present invention relates to a dual activity domain JAK proteins, namely JH2. It is provided that the JH2 domain is a true and important target for drug development, especially for diseases caused by aberrant JAK signalling, such as myeloproliferative disorders and leukemias.
    Type: Application
    Filed: February 10, 2011
    Publication date: December 6, 2012
    Applicant: GENON BIOTECHNOLOGIES OY
    Inventors: Olli Silvennoinen, Daniela Ungureanu